Evolution of CAR T-Cell Therapy
CAR T-cell therapy represents a novel class of immunotherapy and its use has been expanding in relapsed or refractory hematologic malignancies. To ensure optimal patient outcomes, treatment-related toxicities must be closely monitored and quickly managed.
Category
  • Acute Lymphoblastic Leukemia
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Keeping up with the Molecular Targets in the Treatment of Advanced Non-Small Cell Lung Cancer
Nurses and other health care providers need to be familiar with the new approved agents (and their corresponding molecular biomarkers) and side effects associated with the newer agents, so they can improve care for their patients.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Navigating Treatment Selection for Patients with Advanced Ovarian Cancer
Multidisciplinary involvement, including nursing and palliative care specialists, is key to providing the best care possible for patients with recurrent/refractory ovarian cancer.
Category
  • Ovarian Cancer
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Current Clinical Challenges in Cancer Pain Management
To ensure safe and appropriate access to opioid pain medications for their patients, clinicians need to understand the benefits of opioids and develop strategies to ensure adequate pain management for patients in minority ethnic groups and those at risk for opioid misuse.
Category
  • Pain
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Advancing Survivorship Care through Program Development
With increased knowledge of the issues survivors face and optimal ways care can be delivered, nurses can be empowered to help cancer survivors live long and healthy lives after treatment ends.
Category
  • Survivorship
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Telemedicine and Cancer Care: Lessons for the Future
A thorough understanding of the benefits and challenges that can arise from the use of telemedicine in cancer care can help physicians make more informed choices regarding in-person versus virtual care in the post-pandemic future.​​​​​​​
Category
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Optimal Management of Venous Thromboembolism in Patients with Cancer
Surveys suggest that patient and clinician education on cancer-associated VTE and safe use of DOACs is lacking, despite the fact that VTE is a major contributor to mortality among cancer patients.
Category
  • Venous Thromboembolic Disease
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Survivorship: From Adolescents and Young Adults to Older Adults
It is critical for clinicians providing survivorship care to be informed about possible late and long-term effects and appropriate screening and management strategies for them. With this information, clinicians can overcome the barriers to optimal survivorship care, improve patient outcomes, and ensure that all of a survivor’s needs are addressed.
Category
  • Survivorship
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Multidisciplinary Treatment of Early-Stage Non-Small Cell Lung Cancer
Before a specific multidisciplinary treatment plan is recommended for an individual patient, multidisciplinary evaluation in tumor boards is often advised to ensure the patient receives the most appropriate treatment. The multidisciplinary team approach has been shown to improve outcomes in patients with lung cancer.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Multidisciplinary Treatment of Prostate Cancer
Optimal treatment of prostate cancer requires a multidisciplinary team approach, with expertise needed in medical oncology, radiation oncology, urology, genetics, pathology, diagnostic radiology, and supportive care. It is important for clinicians who treat patients with prostate cancer to understand all facets of comprehensive care so that their patients receive the best possible treatments with effective management of side effects.
Category
  • Prostate Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages